Director of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), Bolzon Bradley J Phd, sells 4,500 shares worth $151,984
According to Black Diamond Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 17 07:28 PM, company Director, Bolzon Bradley J Phd disclosed selling 4,500 shares at a cost of $33.77. At the time of this transaction (Nov 13), this trade was worth $151,984 in total. As of Nov 13, Bolzon Bradley J Phd now owns 984,692 shares in total worth about $32,396,366.799999997.
For the last few recent trades made by Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Director, Bolzon Bradley J Phd, we have the following information:
- SEC Form 4 filing: Nov 16: Sold 200 shares at the rate of $33.01 per share. Total worth of this trade was $6,603. Total number of shares owned as of Nov 16 were 984,669
- SEC Form 4 filing: Nov 12: Sold 15,598 shares at the rate of $34.15 per share. Total worth of this trade was $532,642. Total number of shares owned as of Nov 12 were 985,217
- SEC Form 4 filing: Nov 10: Sold 26,966 shares at the rate of $33.83 per share. Total worth of this trade was $912,136. Total number of shares owned as of Nov 10 were 988,507
Posted by
George Daniels
on Tuesday November 17 2020, 10:39 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
